or
forgot password
  • cancer clinical trials in kansas city, MO

  • Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    North Kansas City Hospital

    Trial Locations
    North Kansas City Hospital
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Parvin Radiation Oncology
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    Saint Luke's Cancer Institute at Saint Luke's Hospital

    Trial Locations
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Parvin Radiation Oncology
    Lung Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Heartland Hematology Oncology Associates, Incorporated

    Trial Locations
    Heartland Hematology Oncology Associates, Incorporated
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Parvin Radiation Oncology
    Kansas City Cancer Centers - North
    Kansas City Cancer Centers - South
    Kidney Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Saint Luke's Cancer Institute

    Trial Locations
    Saint Luke's Cancer Institute
    Saint Luke's Hospital of Kansas City
    Saint Joseph Health Center
    Liberty Radiation Oncology Clinic
    Truman Medical Center
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Truman Medical Center - Hospital Hill

    Trial Locations
    Truman Medical Center - Hospital Hill
    Heartland Hematology Oncology Associates, Incorporated
    North Kansas City Hospital
    Saint Luke's Cancer Institute at Saint Luke's Hospital
    Research Medical Center
    Parvin Radiation Oncology
    Kansas City Cancer Centers - North
    Kansas City Cancer Centers - South
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Research Medical Center

    Trial Locations
    Research Medical Center
    Saint Luke's Cancer Institute
    Saint Luke's Hospital of Kansas City
    Saint Joseph Health Center
    Liberty Radiation Oncology Clinic
    Heartland Hematology and Oncology Associates Incorporated
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
    Children's Mercy Hospitals and Clinics
    Kansas City, Missouri 64108
    Sickle Cell Anemia, Sickle ß0-Thalassemia
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    The Childrens Mercy Hospital
    Kansas City, Missouri 64108
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    The Childrens Mercy Hospital
    Kansas City, Missouri 64108
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    North Kansas City Hospital

    Trial Locations
    North Kansas City Hospital
    Research Medical Center
    Saint Luke's Cancer Institute
    Saint Luke's Hospital of Kansas City
    Saint Joseph Health Center
    Liberty Radiation Oncology Clinic
    Truman Medical Center
    Heartland Hematology and Oncology Associates Incorporated
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    A Randomized Controlled Trial Of Endoscopic Ultrasound-Guided Fine-Needle Aspiration With And Without A Stylet
    Veterans Affairs Medical Center
    Kansas City, Missouri 64128
    Mediastinal or Intra-abdominal Lymphadenopathy,, Pancreatic Masses,, Left Adrenal Masses,, Gastrointestinal Submucosal Lesions, and, Liver Masses
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    The Childrens Mercy Hospital
    Kansas City, Missouri 64108
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
    Children's Mercy Hospital

    Trial Locations
    Children's Mercy Hospital
    Research Medical Center
    Sickle Cell Disease
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Research Medical Center

    Trial Locations
    Research Medical Center
    Saint Luke's Cancer Institute
    Saint Luke's Hospital of Kansas City
    Liberty Radiation Oncology Clinic
    Heartland Hematology and Oncology Associates Incorporated
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Veterans Affairs Medical Center - Kansas City

    Trial Locations
    Veterans Affairs Medical Center - Kansas City
    Truman Medical Center - Hospital Hill
    Kansas City Cancer Centers - North
    Kansas City Cancer Centers - South
    Prostate Cancer